Oligometastatic Prostate Carcinoma: Clinical Trials

1 trial for Oligometastatic Prostate Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow Oligometastatic Prostate Carcinoma: new trials by email Literature Review of Oligometastatic Prostate Carcinoma trials Research Report on Oligometastatic Prostate Carcinoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer
[Ac-225]-PSMA-62 (mCRPC), [Ac-225]-PSMA-62 (OmHSPC) - Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
Phase 1Active not recruitingEli Lilly and Company1422024-04-032026-10-06

Narrower conditions

Genital Neoplasms, Male (1)  ·  Prostatic Neoplasms (1)  ·  Urogenital Neoplasms (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Prostatic Diseases (1)  ·  Urogenital Diseases (1)

Sponsors

Eli Lilly and Company (1)

Countries

Canada (1)